Latest filing published 17 Mar 2026 for SHOULDER INNOVATIONS, INC., €26k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -5.0%Entry 13.57 · Close at T+90 12.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeffrey S. Points: trading record in brief
Jeffrey S. Points, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Cardiovascular Systems Inc and Shoulder Innovations, Inc. We count 49 filings; the first trade dates from 18 May 2018 and the latest from 13 March 2026.
Market trades split into 9 purchases (€202k) and 3 sales (€155k). Purchases outweigh sales by €46k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 27 share grants and 2 option exercises. So far in 2026, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €26k. Of 9 purchases, 8 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 17 March 2026: an open-market purchase of €26k, in Shoulder Innovations, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeffrey S. Points
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$15.0018.5% of flowCommon StockSEC:0001731414-26-000003:1Canonical exit: 11 Jun 2026 (T+90)
- 13,264 shares@ US$2.480435.3% of flowCommon StockSEC:0001731414-26-000003:0
- 1,076 shares@ US$12.1613.8% of flowCommon StockSEC:0001731414-26-000001:0
- 1,005 shares@ US$14.989.1% of flowCommon StockSEC:0001628280-25-057080:1Canonical exit: 12 Mar 2026 (T+90)
- 995 shares@ US$14.6515.4% of flowCommon StockSEC:0001628280-25-057080:0Canonical exit: 11 Mar 2026 (T+90)
- 1,600 shares@ US$15.6715.1% of flowCommon StockSEC:0001493152-25-013488:1Canonical exit: 11 Dec 2025 (T+90)
- 13,264 shares@ US$2.480434.7% of flowCommon StockSEC:0001493152-25-013488:0
- 50 shares@ US$15.000.8% of flowCommon StockSEC:0001641172-25-022250:0Canonical exit: 30 Oct 2025 (T+90)
- 34,051 shares@ US$20.0015.5% of flowCommon StockSEC:0001062993-23-009609:1
- 138,957 shares@ US$20.0090.6% of flowCommon StockSEC:0001062993-23-009609:0
- 5,077 shares0Common StockSEC:0001062993-23-003434:1
- 984 shares@ US$19.700.6% of flowCommon StockSEC:0001062993-23-003434:0
- 12,752 shares0Common StockSEC:0001437749-22-021196:0
- 3,308 shares@ US$16.641.9% of flowCommon StockSEC:0001437749-22-020766:0
- 56,747 shares0Common StockSEC:0001437749-22-019620:1
- 18,916 shares0Common StockSEC:0001437749-22-019620:0
- 3,000 shares@ US$14.49871.5% of flowCommon StockSEC:0001437749-22-013312:0Canonical exit: 18 Aug 2022 (T+90)
- 5,477 shares0Common StockSEC:0001437749-22-002876:1
- 2,000 shares@ US$18.201.1% of flowCommon StockSEC:0001437749-22-002876:0Canonical exit: 9 May 2022 (T+90)
- 778 shares@ US$35.380.8% of flowCommon StockSEC:0000914190-21-000314:0
- 4,680 shares@ US$36.184.3% of flowCommon StockSEC:0000914190-21-000296:1
- 4,714 shares0Common StockSEC:0000914190-21-000296:0
- 2,102 shares@ US$36.072.3% of flowCommon StockSEC:0000914190-21-000274:0
- 7,352 shares0Common StockSEC:0000914190-21-000236:1
- 22,055 shares0Common StockSEC:0000914190-21-000236:2
25 of 49 declarations
